Algert Global LLC Fibrogen Inc Transaction History

Algert Global LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.79 - $2.83 $105,934 - $379,486	134,094 Added 488.4%	161,550 $139,000
Q2 2023 Aug 14, 2023	BUY	$2.49 - $20.59 $68,365 - $565,319	27,456 New	27,456 $74,000
Q3 2022 Nov 15, 2022	SELL	$11.4 - $14.6 $127,497 - $163,286	-11,184 Reduced 30.69%	25,256 $329,000
Q2 2022 Aug 15, 2022	BUY	$7.94 - $12.96 $289,333 - $472,262	36,440 New	36,440 $385,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.